VLP Law Group LLP is pleased to announce the addition of Jeremy A. Cubert and Richard N. Kimball. Jeremy will join the Intellectual Property Practice Group as a partner based in the Washington D.C. area. Richard, based in Boston, focuses on corporate and transaction matters.
Jeremy A. Cubert joins VLP with over 17 years of experience in intellectual property law with a focus in the life sciences. He assists companies in all aspects of protecting and managing their intellectual property portfolios, including a significant practice in IP due diligence and portfolio analysis as well as counseling clients regarding the acquisition and licensing of intellectual property assets.
“We are excited to have Jeremy join our Intellectual Property practice. His experience compliments our group and deepens our expertise in life sciences and biotechnology,” says David Roise, Chair of the firm’s Intellectual Property Group. “I look forward to working with Jeremy.”
Before joining VLP, Jeremy was partner in the Intellectual Property Group at Dickstein Shapiro in Washington, DC and a partner at the Clinical Technology Transfer Group in McLean, Virginia. Prior to that, he was also a staff attorney at the Federal Trade Commission and Technology Transfer Specialist at the National Cancer Institute (NCI) at the National Institutes of Health (NIH). Jeremy is a graduate of the George Mason University School of Law, and holds a Master’s Degree in Biochemistry and Molecular Biology from the University of Medicine and Dentistry of New Jersey, and a B.A. in Biology from Rutgers University. He is admitted to the bars of the District of Columbia, Maryland and the USPTO.
“Joining VLP will provide my practice and clients the flexibility in staffing, fee structure and the
technology platform that will help to advance the services that I can provide. I look forward to
working more in-depth with my clients and the VLP team,” stated Jeremy.
Richard N. Kimball joins VLP as a member of the firm’s Corporate, Emerging Growth Companies & Venture Capital, Mergers & Acquisitions, and Securities & Capital Raising Practice Groups. Richard has over 23 years of experience representing investors and issuers in more than 200 domestic and international venture capital financing transactions of technology and life sciences companies and over a dozen issuers in initial public offerings before the Securities and Exchange Commission.
“Richard’s work and experience adds to VLP’s depth and expertise, particularly working with emerging growth companies and the investors that finance and support them” stated Christopher La Chance, Founding Partner of VLP and Chair of the Corporate, Emerging Growth & Start-up Companies, Mergers & Acquisitions and Securities & Capital Raising Practice Groups. “We are excited about the continued growth in VLP’s corporate practice and we are
pleased to have Richard join the VLP team.”
Prior to joining VLP, Richard was a Corporate Partner at Edwards Wildman Palmer LLP. He is admitted to the State Bar of Massachusetts. Richard received his B.S. from the University of Massachusetts and his J.D. from Harvard Law School. “VLP has the perfect blend of experienced attorneys and flexible and top-notch infrastructure,” Richard stated. ”I look forward to working with a talented group of lawyers to support my clients.”
- King & Spalding Recruits Duley to Anchor Life Sciences Transactions Practice
- Perkins Coie Expands Emerging Company & Venture Capital Practice in Palo Alto
- WilmerHale Expands Life Sciences and Emerging Company Practices in Silicon Valley with New Partner
- Troutman Sanders Expansion Continues on West Coast
- Fenwick & West Adds Life Sciences Technology Transaction Partner Jake Handy